Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Research Report 2026(Status and Outlook)
Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody is an antibody specific for CEACAM5 protein. CEACAM5, also known as fetal antigen 5 (CEA), is a membranous cell adhesion molecule that is often expressed on the surface of a variety of cancer cells, especially in cancers of the digestive tract, pancreas, and breast.This antibody can bind to CEACAM5 protein to help detect and localize cancer cells, and can also be used in immunohistochemistry and cancer diagnosis. Due to the high expression of CEACAM5 in cancer, CEACAM5 antibodies have potential applications in tumor marker research and clinical diagnosis, helping to detect and monitor early cancer.
The global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody market size was estimated at USD 493.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 12.40% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody market.
Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Sino Biological, Inc.
LifeSpan BioSciences, Inc
Abcam
Thermo Fisher Scientific (China) Co., Ltd.
Bio-Techne
Boster Biological Technology
Merck
RayBiotech, Inc.
Assay Genie
Creative Biolabs
MyBiosource, Inc.
OriGene Technologies, Inc.
Creative Diagnostics
Abbexa
Biorbyt
Abeomics Inc.
CUSABIO
Enzo Life Sciences, Inc.
Market Segmentation (by Type)
Monoclonal Antibody
Polyclonal Antibody
Market Segmentation (by Application)
Flow Cytometry
ELISA
Western Blot
Immunoprecipitation
Others
Geographic Segmentation
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market
Overview of the regional outlook of the Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody market size was estimated at USD 493.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 12.40% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody market.
Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Sino Biological, Inc.
LifeSpan BioSciences, Inc
Abcam
Thermo Fisher Scientific (China) Co., Ltd.
Bio-Techne
Boster Biological Technology
Merck
RayBiotech, Inc.
Assay Genie
Creative Biolabs
MyBiosource, Inc.
OriGene Technologies, Inc.
Creative Diagnostics
Abbexa
Biorbyt
Abeomics Inc.
CUSABIO
Enzo Life Sciences, Inc.
Market Segmentation (by Type)
Monoclonal Antibody
Polyclonal Antibody
Market Segmentation (by Application)
Flow Cytometry
ELISA
Western Blot
Immunoprecipitation
Others
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market
Overview of the regional outlook of the Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody
1.2 Key Market Segments
1.2.1 Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Segment by Type
1.2.2 Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 CARCINOEMBRYONIC ANTIGEN-RELATED CELL ADHESION MOLECULE 5 (CEACAM5) ANTIBODY MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 CARCINOEMBRYONIC ANTIGEN-RELATED CELL ADHESION MOLECULE 5 (CEACAM5) ANTIBODY MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product Life Cycle
3.3 Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales by Manufacturers (2020-2025)
3.4 Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Revenue Market Share by Manufacturers (2020-2025)
3.5 Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Competitive Situation and Trends
3.8.1 Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Concentration Rate
3.8.2 Global 5 and 10 Largest Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 CARCINOEMBRYONIC ANTIGEN-RELATED CELL ADHESION MOLECULE 5 (CEACAM5) ANTIBODY INDUSTRY CHAIN ANALYSIS
4.1 Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF CARCINOEMBRYONIC ANTIGEN-RELATED CELL ADHESION MOLECULE 5 (CEACAM5) ANTIBODY MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market
5.7 ESG Ratings of Leading Companies
6 CARCINOEMBRYONIC ANTIGEN-RELATED CELL ADHESION MOLECULE 5 (CEACAM5) ANTIBODY MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales Market Share by Type (2020-2025)
6.3 Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Size by Type (2020-2025)
6.4 Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Price by Type (2020-2025)
7 CARCINOEMBRYONIC ANTIGEN-RELATED CELL ADHESION MOLECULE 5 (CEACAM5) ANTIBODY MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Sales by Application (2020-2025)
7.3 Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Size (M USD) by Application (2020-2025)
7.4 Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales Growth Rate by Application (2020-2025)
8 CARCINOEMBRYONIC ANTIGEN-RELATED CELL ADHESION MOLECULE 5 (CEACAM5) ANTIBODY MARKET SALES BY REGION
8.1 Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales by Region
8.1.1 Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales by Region
8.1.2 Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales Market Share by Region
8.2 Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Size by Region
8.2.1 Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Size by Region
8.2.2 Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Size by Region
8.3 North America
8.3.1 North America Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales by Country
8.3.2 North America Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales by Country
8.4.2 Europe Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales by Region
8.5.2 Asia Pacific Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales by Country
8.6.2 South America Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales by Region
8.7.2 Middle East and Africa Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 CARCINOEMBRYONIC ANTIGEN-RELATED CELL ADHESION MOLECULE 5 (CEACAM5) ANTIBODY MARKET PRODUCTION BY REGION
9.1 Global Production of Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody by Region(2020-2025)
9.2 Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Revenue Market Share by Region (2020-2025)
9.3 Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production
9.4.1 North America Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production Growth Rate (2020-2025)
9.4.2 North America Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production
9.5.1 Europe Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production Growth Rate (2020-2025)
9.5.2 Europe Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production (2020-2025)
9.6.1 Japan Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production Growth Rate (2020-2025)
9.6.2 Japan Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production (2020-2025)
9.7.1 China Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production Growth Rate (2020-2025)
9.7.2 China Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Sino Biological, Inc.
10.1.1 Sino Biological, Inc. Basic Information
10.1.2 Sino Biological, Inc. Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product Overview
10.1.3 Sino Biological, Inc. Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product Market Performance
10.1.4 Sino Biological, Inc. Business Overview
10.1.5 Sino Biological, Inc. SWOT Analysis
10.1.6 Sino Biological, Inc. Recent Developments
10.2 LifeSpan BioSciences, Inc
10.2.1 LifeSpan BioSciences, Inc Basic Information
10.2.2 LifeSpan BioSciences, Inc Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product Overview
10.2.3 LifeSpan BioSciences, Inc Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product Market Performance
10.2.4 LifeSpan BioSciences, Inc Business Overview
10.2.5 LifeSpan BioSciences, Inc SWOT Analysis
10.2.6 LifeSpan BioSciences, Inc Recent Developments
10.3 Abcam
10.3.1 Abcam Basic Information
10.3.2 Abcam Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product Overview
10.3.3 Abcam Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product Market Performance
10.3.4 Abcam Business Overview
10.3.5 Abcam SWOT Analysis
10.3.6 Abcam Recent Developments
10.4 Thermo Fisher Scientific (China) Co., Ltd.
10.4.1 Thermo Fisher Scientific (China) Co., Ltd. Basic Information
10.4.2 Thermo Fisher Scientific (China) Co., Ltd. Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product Overview
10.4.3 Thermo Fisher Scientific (China) Co., Ltd. Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product Market Performance
10.4.4 Thermo Fisher Scientific (China) Co., Ltd. Business Overview
10.4.5 Thermo Fisher Scientific (China) Co., Ltd. Recent Developments
10.5 Bio-Techne
10.5.1 Bio-Techne Basic Information
10.5.2 Bio-Techne Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product Overview
10.5.3 Bio-Techne Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product Market Performance
10.5.4 Bio-Techne Business Overview
10.5.5 Bio-Techne Recent Developments
10.6 Boster Biological Technology
10.6.1 Boster Biological Technology Basic Information
10.6.2 Boster Biological Technology Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product Overview
10.6.3 Boster Biological Technology Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product Market Performance
10.6.4 Boster Biological Technology Business Overview
10.6.5 Boster Biological Technology Recent Developments
10.7 Merck
10.7.1 Merck Basic Information
10.7.2 Merck Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product Overview
10.7.3 Merck Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product Market Performance
10.7.4 Merck Business Overview
10.7.5 Merck Recent Developments
10.8 RayBiotech, Inc.
10.8.1 RayBiotech, Inc. Basic Information
10.8.2 RayBiotech, Inc. Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product Overview
10.8.3 RayBiotech, Inc. Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product Market Performance
10.8.4 RayBiotech, Inc. Business Overview
10.8.5 RayBiotech, Inc. Recent Developments
10.9 Assay Genie
10.9.1 Assay Genie Basic Information
10.9.2 Assay Genie Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product Overview
10.9.3 Assay Genie Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product Market Performance
10.9.4 Assay Genie Business Overview
10.9.5 Assay Genie Recent Developments
10.10 Creative Biolabs
10.10.1 Creative Biolabs Basic Information
10.10.2 Creative Biolabs Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product Overview
10.10.3 Creative Biolabs Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product Market Performance
10.10.4 Creative Biolabs Business Overview
10.10.5 Creative Biolabs Recent Developments
10.11 MyBiosource, Inc.
10.11.1 MyBiosource, Inc. Basic Information
10.11.2 MyBiosource, Inc. Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product Overview
10.11.3 MyBiosource, Inc. Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product Market Performance
10.11.4 MyBiosource, Inc. Business Overview
10.11.5 MyBiosource, Inc. Recent Developments
10.12 OriGene Technologies, Inc.
10.12.1 OriGene Technologies, Inc. Basic Information
10.12.2 OriGene Technologies, Inc. Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product Overview
10.12.3 OriGene Technologies, Inc. Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product Market Performance
10.12.4 OriGene Technologies, Inc. Business Overview
10.12.5 OriGene Technologies, Inc. Recent Developments
10.13 Creative Diagnostics
10.13.1 Creative Diagnostics Basic Information
10.13.2 Creative Diagnostics Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product Overview
10.13.3 Creative Diagnostics Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product Market Performance
10.13.4 Creative Diagnostics Business Overview
10.13.5 Creative Diagnostics Recent Developments
10.14 Abbexa
10.14.1 Abbexa Basic Information
10.14.2 Abbexa Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product Overview
10.14.3 Abbexa Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product Market Performance
10.14.4 Abbexa Business Overview
10.14.5 Abbexa Recent Developments
10.15 Biorbyt
10.15.1 Biorbyt Basic Information
10.15.2 Biorbyt Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product Overview
10.15.3 Biorbyt Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product Market Performance
10.15.4 Biorbyt Business Overview
10.15.5 Biorbyt Recent Developments
10.16 Abeomics Inc.
10.16.1 Abeomics Inc. Basic Information
10.16.2 Abeomics Inc. Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product Overview
10.16.3 Abeomics Inc. Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product Market Performance
10.16.4 Abeomics Inc. Business Overview
10.16.5 Abeomics Inc. Recent Developments
10.17 CUSABIO
10.17.1 CUSABIO Basic Information
10.17.2 CUSABIO Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product Overview
10.17.3 CUSABIO Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product Market Performance
10.17.4 CUSABIO Business Overview
10.17.5 CUSABIO Recent Developments
10.18 Enzo Life Sciences, Inc.
10.18.1 Enzo Life Sciences, Inc. Basic Information
10.18.2 Enzo Life Sciences, Inc. Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product Overview
10.18.3 Enzo Life Sciences, Inc. Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product Market Performance
10.18.4 Enzo Life Sciences, Inc. Business Overview
10.18.5 Enzo Life Sciences, Inc. Recent Developments
11 CARCINOEMBRYONIC ANTIGEN-RELATED CELL ADHESION MOLECULE 5 (CEACAM5) ANTIBODY MARKET FORECAST BY REGION
11.1 Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Size Forecast
11.2 Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Size Forecast by Country
11.2.3 Asia Pacific Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Size Forecast by Region
11.2.4 South America Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody by Type (2026-2035)
12.1.2 Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody by Type (2026-2035)
12.2 Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Forecast by Application (2026-2035)
12.2.1 Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales (K MT) Forecast by Application
12.2.2 Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
@LOT
1.1 Market Definition and Statistical Scope of Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody
1.2 Key Market Segments
1.2.1 Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Segment by Type
1.2.2 Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 CARCINOEMBRYONIC ANTIGEN-RELATED CELL ADHESION MOLECULE 5 (CEACAM5) ANTIBODY MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 CARCINOEMBRYONIC ANTIGEN-RELATED CELL ADHESION MOLECULE 5 (CEACAM5) ANTIBODY MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product Life Cycle
3.3 Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales by Manufacturers (2020-2025)
3.4 Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Revenue Market Share by Manufacturers (2020-2025)
3.5 Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Competitive Situation and Trends
3.8.1 Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Concentration Rate
3.8.2 Global 5 and 10 Largest Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 CARCINOEMBRYONIC ANTIGEN-RELATED CELL ADHESION MOLECULE 5 (CEACAM5) ANTIBODY INDUSTRY CHAIN ANALYSIS
4.1 Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF CARCINOEMBRYONIC ANTIGEN-RELATED CELL ADHESION MOLECULE 5 (CEACAM5) ANTIBODY MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market
5.7 ESG Ratings of Leading Companies
6 CARCINOEMBRYONIC ANTIGEN-RELATED CELL ADHESION MOLECULE 5 (CEACAM5) ANTIBODY MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales Market Share by Type (2020-2025)
6.3 Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Size by Type (2020-2025)
6.4 Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Price by Type (2020-2025)
7 CARCINOEMBRYONIC ANTIGEN-RELATED CELL ADHESION MOLECULE 5 (CEACAM5) ANTIBODY MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Sales by Application (2020-2025)
7.3 Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Size (M USD) by Application (2020-2025)
7.4 Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales Growth Rate by Application (2020-2025)
8 CARCINOEMBRYONIC ANTIGEN-RELATED CELL ADHESION MOLECULE 5 (CEACAM5) ANTIBODY MARKET SALES BY REGION
8.1 Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales by Region
8.1.1 Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales by Region
8.1.2 Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales Market Share by Region
8.2 Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Size by Region
8.2.1 Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Size by Region
8.2.2 Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Size by Region
8.3 North America
8.3.1 North America Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales by Country
8.3.2 North America Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales by Country
8.4.2 Europe Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales by Region
8.5.2 Asia Pacific Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales by Country
8.6.2 South America Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales by Region
8.7.2 Middle East and Africa Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 CARCINOEMBRYONIC ANTIGEN-RELATED CELL ADHESION MOLECULE 5 (CEACAM5) ANTIBODY MARKET PRODUCTION BY REGION
9.1 Global Production of Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody by Region(2020-2025)
9.2 Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Revenue Market Share by Region (2020-2025)
9.3 Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production
9.4.1 North America Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production Growth Rate (2020-2025)
9.4.2 North America Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production
9.5.1 Europe Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production Growth Rate (2020-2025)
9.5.2 Europe Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production (2020-2025)
9.6.1 Japan Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production Growth Rate (2020-2025)
9.6.2 Japan Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production (2020-2025)
9.7.1 China Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production Growth Rate (2020-2025)
9.7.2 China Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Sino Biological, Inc.
10.1.1 Sino Biological, Inc. Basic Information
10.1.2 Sino Biological, Inc. Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product Overview
10.1.3 Sino Biological, Inc. Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product Market Performance
10.1.4 Sino Biological, Inc. Business Overview
10.1.5 Sino Biological, Inc. SWOT Analysis
10.1.6 Sino Biological, Inc. Recent Developments
10.2 LifeSpan BioSciences, Inc
10.2.1 LifeSpan BioSciences, Inc Basic Information
10.2.2 LifeSpan BioSciences, Inc Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product Overview
10.2.3 LifeSpan BioSciences, Inc Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product Market Performance
10.2.4 LifeSpan BioSciences, Inc Business Overview
10.2.5 LifeSpan BioSciences, Inc SWOT Analysis
10.2.6 LifeSpan BioSciences, Inc Recent Developments
10.3 Abcam
10.3.1 Abcam Basic Information
10.3.2 Abcam Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product Overview
10.3.3 Abcam Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product Market Performance
10.3.4 Abcam Business Overview
10.3.5 Abcam SWOT Analysis
10.3.6 Abcam Recent Developments
10.4 Thermo Fisher Scientific (China) Co., Ltd.
10.4.1 Thermo Fisher Scientific (China) Co., Ltd. Basic Information
10.4.2 Thermo Fisher Scientific (China) Co., Ltd. Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product Overview
10.4.3 Thermo Fisher Scientific (China) Co., Ltd. Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product Market Performance
10.4.4 Thermo Fisher Scientific (China) Co., Ltd. Business Overview
10.4.5 Thermo Fisher Scientific (China) Co., Ltd. Recent Developments
10.5 Bio-Techne
10.5.1 Bio-Techne Basic Information
10.5.2 Bio-Techne Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product Overview
10.5.3 Bio-Techne Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product Market Performance
10.5.4 Bio-Techne Business Overview
10.5.5 Bio-Techne Recent Developments
10.6 Boster Biological Technology
10.6.1 Boster Biological Technology Basic Information
10.6.2 Boster Biological Technology Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product Overview
10.6.3 Boster Biological Technology Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product Market Performance
10.6.4 Boster Biological Technology Business Overview
10.6.5 Boster Biological Technology Recent Developments
10.7 Merck
10.7.1 Merck Basic Information
10.7.2 Merck Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product Overview
10.7.3 Merck Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product Market Performance
10.7.4 Merck Business Overview
10.7.5 Merck Recent Developments
10.8 RayBiotech, Inc.
10.8.1 RayBiotech, Inc. Basic Information
10.8.2 RayBiotech, Inc. Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product Overview
10.8.3 RayBiotech, Inc. Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product Market Performance
10.8.4 RayBiotech, Inc. Business Overview
10.8.5 RayBiotech, Inc. Recent Developments
10.9 Assay Genie
10.9.1 Assay Genie Basic Information
10.9.2 Assay Genie Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product Overview
10.9.3 Assay Genie Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product Market Performance
10.9.4 Assay Genie Business Overview
10.9.5 Assay Genie Recent Developments
10.10 Creative Biolabs
10.10.1 Creative Biolabs Basic Information
10.10.2 Creative Biolabs Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product Overview
10.10.3 Creative Biolabs Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product Market Performance
10.10.4 Creative Biolabs Business Overview
10.10.5 Creative Biolabs Recent Developments
10.11 MyBiosource, Inc.
10.11.1 MyBiosource, Inc. Basic Information
10.11.2 MyBiosource, Inc. Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product Overview
10.11.3 MyBiosource, Inc. Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product Market Performance
10.11.4 MyBiosource, Inc. Business Overview
10.11.5 MyBiosource, Inc. Recent Developments
10.12 OriGene Technologies, Inc.
10.12.1 OriGene Technologies, Inc. Basic Information
10.12.2 OriGene Technologies, Inc. Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product Overview
10.12.3 OriGene Technologies, Inc. Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product Market Performance
10.12.4 OriGene Technologies, Inc. Business Overview
10.12.5 OriGene Technologies, Inc. Recent Developments
10.13 Creative Diagnostics
10.13.1 Creative Diagnostics Basic Information
10.13.2 Creative Diagnostics Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product Overview
10.13.3 Creative Diagnostics Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product Market Performance
10.13.4 Creative Diagnostics Business Overview
10.13.5 Creative Diagnostics Recent Developments
10.14 Abbexa
10.14.1 Abbexa Basic Information
10.14.2 Abbexa Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product Overview
10.14.3 Abbexa Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product Market Performance
10.14.4 Abbexa Business Overview
10.14.5 Abbexa Recent Developments
10.15 Biorbyt
10.15.1 Biorbyt Basic Information
10.15.2 Biorbyt Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product Overview
10.15.3 Biorbyt Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product Market Performance
10.15.4 Biorbyt Business Overview
10.15.5 Biorbyt Recent Developments
10.16 Abeomics Inc.
10.16.1 Abeomics Inc. Basic Information
10.16.2 Abeomics Inc. Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product Overview
10.16.3 Abeomics Inc. Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product Market Performance
10.16.4 Abeomics Inc. Business Overview
10.16.5 Abeomics Inc. Recent Developments
10.17 CUSABIO
10.17.1 CUSABIO Basic Information
10.17.2 CUSABIO Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product Overview
10.17.3 CUSABIO Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product Market Performance
10.17.4 CUSABIO Business Overview
10.17.5 CUSABIO Recent Developments
10.18 Enzo Life Sciences, Inc.
10.18.1 Enzo Life Sciences, Inc. Basic Information
10.18.2 Enzo Life Sciences, Inc. Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product Overview
10.18.3 Enzo Life Sciences, Inc. Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product Market Performance
10.18.4 Enzo Life Sciences, Inc. Business Overview
10.18.5 Enzo Life Sciences, Inc. Recent Developments
11 CARCINOEMBRYONIC ANTIGEN-RELATED CELL ADHESION MOLECULE 5 (CEACAM5) ANTIBODY MARKET FORECAST BY REGION
11.1 Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Size Forecast
11.2 Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Size Forecast by Country
11.2.3 Asia Pacific Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Size Forecast by Region
11.2.4 South America Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody by Type (2026-2035)
12.1.2 Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody by Type (2026-2035)
12.2 Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Forecast by Application (2026-2035)
12.2.1 Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales (K MT) Forecast by Application
12.2.2 Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
@LOT
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Size by Type (M USD)
Table 4. Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Size by Application
Table 5. Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Size Comparison by Region (M USD)
Table 6. Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody as of 2025)
Table 11. Global Market Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales by Type (K MT)
Table 27. Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Size by Type (M USD)
Table 28. Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales (K MT) by Type (2020-2025)
Table 29. Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales Market Share by Type (2020-2025)
Table 30. Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Size (M USD) by Type (2020-2025)
Table 31. Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Share by Type (2020-2025)
Table 32. Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Price (USD/KG) by Type (2020-2025)
Table 33. Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales (K MT) by Application
Table 34. Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Size by Application
Table 35. Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales by Application (2020-2025) & (K MT)
Table 36. Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales Market Share by Application (2020-2025)
Table 37. Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Size by Application (2020-2025) & (M USD)
Table 38. Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Share by Application (2020-2025)
Table 39. Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales Growth Rate by Application (2020-2025)
Table 40. Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales by Region (2020-2025) & (K MT)
Table 41. Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales Market Share by Region (2020-2025)
Table 42. Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Size by Region (2020-2025) & (M USD)
Table 43. Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Size by Region (2020-2025)
Table 44. North America Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales by Country (2020-2025) & (K MT)
Table 45. North America Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales by Country (2020-2025) & (K MT)
Table 47. Europe Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Size by Region (2020-2025) & (M USD)
Table 50. South America Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales by Country (2020-2025) & (K MT)
Table 51. South America Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Size by Region (2020-2025) & (M USD)
Table 54. Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production (K MT) by Region(2020-2025)
Table 55. Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Revenue Market Share by Region (2020-2025)
Table 57. Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Sino Biological, Inc. Basic Information
Table 63. Sino Biological, Inc. Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product Overview
Table 64. Sino Biological, Inc. Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Sino Biological, Inc. Business Overview
Table 66. Sino Biological, Inc. SWOT Analysis
Table 67. Sino Biological, Inc. Recent Developments
Table 68. LifeSpan BioSciences, Inc Basic Information
Table 69. LifeSpan BioSciences, Inc Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product Overview
Table 70. LifeSpan BioSciences, Inc Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. LifeSpan BioSciences, Inc Business Overview
Table 72. LifeSpan BioSciences, Inc SWOT Analysis
Table 73. LifeSpan BioSciences, Inc Recent Developments
Table 74. Abcam Basic Information
Table 75. Abcam Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product Overview
Table 76. Abcam Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Abcam Business Overview
Table 78. Abcam SWOT Analysis
Table 79. Abcam Recent Developments
Table 80. Thermo Fisher Scientific (China) Co., Ltd. Basic Information
Table 81. Thermo Fisher Scientific (China) Co., Ltd. Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product Overview
Table 82. Thermo Fisher Scientific (China) Co., Ltd. Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Thermo Fisher Scientific (China) Co., Ltd. Business Overview
Table 84. Thermo Fisher Scientific (China) Co., Ltd. Recent Developments
Table 85. Bio-Techne Basic Information
Table 86. Bio-Techne Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product Overview
Table 87. Bio-Techne Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Bio-Techne Business Overview
Table 89. Bio-Techne Recent Developments
Table 90. Boster Biological Technology Basic Information
Table 91. Boster Biological Technology Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product Overview
Table 92. Boster Biological Technology Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Boster Biological Technology Business Overview
Table 94. Boster Biological Technology Recent Developments
Table 95. Merck Basic Information
Table 96. Merck Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product Overview
Table 97. Merck Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Merck Business Overview
Table 99. Merck Recent Developments
Table 100. RayBiotech, Inc. Basic Information
Table 101. RayBiotech, Inc. Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product Overview
Table 102. RayBiotech, Inc. Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. RayBiotech, Inc. Business Overview
Table 104. RayBiotech, Inc. Recent Developments
Table 105. Assay Genie Basic Information
Table 106. Assay Genie Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product Overview
Table 107. Assay Genie Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. Assay Genie Business Overview
Table 109. Assay Genie Recent Developments
Table 110. Creative Biolabs Basic Information
Table 111. Creative Biolabs Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product Overview
Table 112. Creative Biolabs Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. Creative Biolabs Business Overview
Table 114. Creative Biolabs Recent Developments
Table 115. MyBiosource, Inc. Basic Information
Table 116. MyBiosource, Inc. Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product Overview
Table 117. MyBiosource, Inc. Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 118. MyBiosource, Inc. Business Overview
Table 119. MyBiosource, Inc. Recent Developments
Table 120. OriGene Technologies, Inc. Basic Information
Table 121. OriGene Technologies, Inc. Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product Overview
Table 122. OriGene Technologies, Inc. Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 123. OriGene Technologies, Inc. Business Overview
Table 124. OriGene Technologies, Inc. Recent Developments
Table 125. Creative Diagnostics Basic Information
Table 126. Creative Diagnostics Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product Overview
Table 127. Creative Diagnostics Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 128. Creative Diagnostics Business Overview
Table 129. Creative Diagnostics Recent Developments
Table 130. Abbexa Basic Information
Table 131. Abbexa Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product Overview
Table 132. Abbexa Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 133. Abbexa Business Overview
Table 134. Abbexa Recent Developments
Table 135. Biorbyt Basic Information
Table 136. Biorbyt Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product Overview
Table 137. Biorbyt Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 138. Biorbyt Business Overview
Table 139. Biorbyt Recent Developments
Table 140. Abeomics Inc. Basic Information
Table 141. Abeomics Inc. Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product Overview
Table 142. Abeomics Inc. Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 143. Abeomics Inc. Business Overview
Table 144. Abeomics Inc. Recent Developments
Table 145. CUSABIO Basic Information
Table 146. CUSABIO Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product Overview
Table 147. CUSABIO Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 148. CUSABIO Business Overview
Table 149. CUSABIO Recent Developments
Table 150. Enzo Life Sciences, Inc. Basic Information
Table 151. Enzo Life Sciences, Inc. Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product Overview
Table 152. Enzo Life Sciences, Inc. Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 153. Enzo Life Sciences, Inc. Business Overview
Table 154. Enzo Life Sciences, Inc. Recent Developments
Table 155. Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales Forecast by Region (2026-2035) & (K MT)
Table 156. Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Size Forecast by Region (2026-2035) & (M USD)
Table 157. North America Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales Forecast by Country (2026-2035) & (K MT)
Table 158. North America Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Size Forecast by Country (2026-2035) & (M USD)
Table 159. Europe Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales Forecast by Country (2026-2035) & (K MT)
Table 160. Europe Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Size Forecast by Country (2026-2035) & (M USD)
Table 161. Asia Pacific Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales Forecast by Region (2026-2035) & (K MT)
Table 162. Asia Pacific Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Size Forecast by Region (2026-2035) & (M USD)
Table 163. South America Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales Forecast by Country (2026-2035) & (K MT)
Table 164. South America Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Size Forecast by Country (2026-2035) & (M USD)
Table 165. Middle East and Africa Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales Forecast by Country (2026-2035) & (Units)
Table 166. Middle East and Africa Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Size Forecast by Country (2026-2035) & (M USD)
Table 167. Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales Forecast by Type (2026-2035) & (K MT)
Table 168. Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Size Forecast by Type (2026-2035) & (M USD)
Table 169. Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Price Forecast by Type (2026-2035) & (USD/KG)
Table 170. Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales (K MT) Forecast by Application (2026-2035)
Table 171. Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Size by Type (M USD)
Table 4. Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Size by Application
Table 5. Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Size Comparison by Region (M USD)
Table 6. Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody as of 2025)
Table 11. Global Market Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales by Type (K MT)
Table 27. Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Size by Type (M USD)
Table 28. Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales (K MT) by Type (2020-2025)
Table 29. Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales Market Share by Type (2020-2025)
Table 30. Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Size (M USD) by Type (2020-2025)
Table 31. Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Share by Type (2020-2025)
Table 32. Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Price (USD/KG) by Type (2020-2025)
Table 33. Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales (K MT) by Application
Table 34. Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Size by Application
Table 35. Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales by Application (2020-2025) & (K MT)
Table 36. Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales Market Share by Application (2020-2025)
Table 37. Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Size by Application (2020-2025) & (M USD)
Table 38. Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Share by Application (2020-2025)
Table 39. Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales Growth Rate by Application (2020-2025)
Table 40. Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales by Region (2020-2025) & (K MT)
Table 41. Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales Market Share by Region (2020-2025)
Table 42. Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Size by Region (2020-2025) & (M USD)
Table 43. Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Size by Region (2020-2025)
Table 44. North America Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales by Country (2020-2025) & (K MT)
Table 45. North America Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales by Country (2020-2025) & (K MT)
Table 47. Europe Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Size by Region (2020-2025) & (M USD)
Table 50. South America Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales by Country (2020-2025) & (K MT)
Table 51. South America Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Size by Region (2020-2025) & (M USD)
Table 54. Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production (K MT) by Region(2020-2025)
Table 55. Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Revenue Market Share by Region (2020-2025)
Table 57. Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Sino Biological, Inc. Basic Information
Table 63. Sino Biological, Inc. Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product Overview
Table 64. Sino Biological, Inc. Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Sino Biological, Inc. Business Overview
Table 66. Sino Biological, Inc. SWOT Analysis
Table 67. Sino Biological, Inc. Recent Developments
Table 68. LifeSpan BioSciences, Inc Basic Information
Table 69. LifeSpan BioSciences, Inc Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product Overview
Table 70. LifeSpan BioSciences, Inc Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. LifeSpan BioSciences, Inc Business Overview
Table 72. LifeSpan BioSciences, Inc SWOT Analysis
Table 73. LifeSpan BioSciences, Inc Recent Developments
Table 74. Abcam Basic Information
Table 75. Abcam Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product Overview
Table 76. Abcam Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Abcam Business Overview
Table 78. Abcam SWOT Analysis
Table 79. Abcam Recent Developments
Table 80. Thermo Fisher Scientific (China) Co., Ltd. Basic Information
Table 81. Thermo Fisher Scientific (China) Co., Ltd. Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product Overview
Table 82. Thermo Fisher Scientific (China) Co., Ltd. Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Thermo Fisher Scientific (China) Co., Ltd. Business Overview
Table 84. Thermo Fisher Scientific (China) Co., Ltd. Recent Developments
Table 85. Bio-Techne Basic Information
Table 86. Bio-Techne Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product Overview
Table 87. Bio-Techne Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Bio-Techne Business Overview
Table 89. Bio-Techne Recent Developments
Table 90. Boster Biological Technology Basic Information
Table 91. Boster Biological Technology Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product Overview
Table 92. Boster Biological Technology Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Boster Biological Technology Business Overview
Table 94. Boster Biological Technology Recent Developments
Table 95. Merck Basic Information
Table 96. Merck Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product Overview
Table 97. Merck Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Merck Business Overview
Table 99. Merck Recent Developments
Table 100. RayBiotech, Inc. Basic Information
Table 101. RayBiotech, Inc. Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product Overview
Table 102. RayBiotech, Inc. Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. RayBiotech, Inc. Business Overview
Table 104. RayBiotech, Inc. Recent Developments
Table 105. Assay Genie Basic Information
Table 106. Assay Genie Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product Overview
Table 107. Assay Genie Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. Assay Genie Business Overview
Table 109. Assay Genie Recent Developments
Table 110. Creative Biolabs Basic Information
Table 111. Creative Biolabs Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product Overview
Table 112. Creative Biolabs Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. Creative Biolabs Business Overview
Table 114. Creative Biolabs Recent Developments
Table 115. MyBiosource, Inc. Basic Information
Table 116. MyBiosource, Inc. Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product Overview
Table 117. MyBiosource, Inc. Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 118. MyBiosource, Inc. Business Overview
Table 119. MyBiosource, Inc. Recent Developments
Table 120. OriGene Technologies, Inc. Basic Information
Table 121. OriGene Technologies, Inc. Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product Overview
Table 122. OriGene Technologies, Inc. Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 123. OriGene Technologies, Inc. Business Overview
Table 124. OriGene Technologies, Inc. Recent Developments
Table 125. Creative Diagnostics Basic Information
Table 126. Creative Diagnostics Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product Overview
Table 127. Creative Diagnostics Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 128. Creative Diagnostics Business Overview
Table 129. Creative Diagnostics Recent Developments
Table 130. Abbexa Basic Information
Table 131. Abbexa Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product Overview
Table 132. Abbexa Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 133. Abbexa Business Overview
Table 134. Abbexa Recent Developments
Table 135. Biorbyt Basic Information
Table 136. Biorbyt Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product Overview
Table 137. Biorbyt Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 138. Biorbyt Business Overview
Table 139. Biorbyt Recent Developments
Table 140. Abeomics Inc. Basic Information
Table 141. Abeomics Inc. Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product Overview
Table 142. Abeomics Inc. Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 143. Abeomics Inc. Business Overview
Table 144. Abeomics Inc. Recent Developments
Table 145. CUSABIO Basic Information
Table 146. CUSABIO Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product Overview
Table 147. CUSABIO Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 148. CUSABIO Business Overview
Table 149. CUSABIO Recent Developments
Table 150. Enzo Life Sciences, Inc. Basic Information
Table 151. Enzo Life Sciences, Inc. Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product Overview
Table 152. Enzo Life Sciences, Inc. Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 153. Enzo Life Sciences, Inc. Business Overview
Table 154. Enzo Life Sciences, Inc. Recent Developments
Table 155. Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales Forecast by Region (2026-2035) & (K MT)
Table 156. Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Size Forecast by Region (2026-2035) & (M USD)
Table 157. North America Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales Forecast by Country (2026-2035) & (K MT)
Table 158. North America Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Size Forecast by Country (2026-2035) & (M USD)
Table 159. Europe Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales Forecast by Country (2026-2035) & (K MT)
Table 160. Europe Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Size Forecast by Country (2026-2035) & (M USD)
Table 161. Asia Pacific Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales Forecast by Region (2026-2035) & (K MT)
Table 162. Asia Pacific Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Size Forecast by Region (2026-2035) & (M USD)
Table 163. South America Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales Forecast by Country (2026-2035) & (K MT)
Table 164. South America Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Size Forecast by Country (2026-2035) & (M USD)
Table 165. Middle East and Africa Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales Forecast by Country (2026-2035) & (Units)
Table 166. Middle East and Africa Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Size Forecast by Country (2026-2035) & (M USD)
Table 167. Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales Forecast by Type (2026-2035) & (K MT)
Table 168. Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Size Forecast by Type (2026-2035) & (M USD)
Table 169. Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Price Forecast by Type (2026-2035) & (USD/KG)
Table 170. Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales (K MT) Forecast by Application (2026-2035)
Table 171. Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Size (M USD), 2025-2035
Figure 5. Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Size (M USD) (2020-2035)
Figure 6. Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product Life Cycle
Figure 13. Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales Share by Manufacturers in 2025
Figure 14. Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Revenue Share by Manufacturers in 2025
Figure 15. Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Revenue in 2025
Figure 18. Industry Chain Map of Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody
Figure 19. Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market PEST Analysis
Figure 20. Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Share by Type
Figure 27. Sales Market Share of Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody by Type (2020-2025)
Figure 28. Sales Market Share of Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody by Type in 2025
Figure 29. Market Share of Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody by Type (2020-2025)
Figure 30. Market Share of Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Share by Application
Figure 33. Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales Market Share by Application (2020-2025)
Figure 34. Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales Market Share by Application in 2025
Figure 35. Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Share by Application (2020-2025)
Figure 36. Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Share by Application in 2025
Figure 37. Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales Growth Rate by Application (2020-2025)
Figure 38. Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales Market Share by Region (2020-2025)
Figure 39. Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Size by Region (2020-2025)
Figure 40. North America Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales Market Share by Country in 2024
Figure 43. North America Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Size by Country in 2024
Figure 45. U.S. Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales Market Share by Country in 2024
Figure 53. Europe Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Size by Country in 2024
Figure 55. Germany Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales Market Share by Region in 2024
Figure 67. Asia Pacific Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Size by Region in 2024
Figure 68. China Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales and Growth Rate (K MT)
Figure 79. South America Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales Market Share by Country in 2024
Figure 80. South America Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Size and Growth Rate (M USD)
Figure 81. South America Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Size by Country in 2024
Figure 82. Brazil Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Size by Region in 2024
Figure 92. Saudi Arabia Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production Market Share by Region (2020-2025)
Figure 103. North America Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production (K MT) Growth Rate (2020-2025)
Figure 106. China Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Share Forecast by Type (2026-2035)
Figure 1. Product Picture of Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Size (M USD), 2025-2035
Figure 5. Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Size (M USD) (2020-2035)
Figure 6. Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Product Life Cycle
Figure 13. Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales Share by Manufacturers in 2025
Figure 14. Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Revenue Share by Manufacturers in 2025
Figure 15. Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Revenue in 2025
Figure 18. Industry Chain Map of Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody
Figure 19. Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market PEST Analysis
Figure 20. Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Share by Type
Figure 27. Sales Market Share of Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody by Type (2020-2025)
Figure 28. Sales Market Share of Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody by Type in 2025
Figure 29. Market Share of Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody by Type (2020-2025)
Figure 30. Market Share of Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Share by Application
Figure 33. Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales Market Share by Application (2020-2025)
Figure 34. Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales Market Share by Application in 2025
Figure 35. Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Share by Application (2020-2025)
Figure 36. Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Share by Application in 2025
Figure 37. Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales Growth Rate by Application (2020-2025)
Figure 38. Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales Market Share by Region (2020-2025)
Figure 39. Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Size by Region (2020-2025)
Figure 40. North America Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales Market Share by Country in 2024
Figure 43. North America Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Size by Country in 2024
Figure 45. U.S. Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales Market Share by Country in 2024
Figure 53. Europe Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Size by Country in 2024
Figure 55. Germany Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales Market Share by Region in 2024
Figure 67. Asia Pacific Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Size by Region in 2024
Figure 68. China Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales and Growth Rate (K MT)
Figure 79. South America Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales Market Share by Country in 2024
Figure 80. South America Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Size and Growth Rate (M USD)
Figure 81. South America Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Size by Country in 2024
Figure 82. Brazil Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Size by Region in 2024
Figure 92. Saudi Arabia Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production Market Share by Region (2020-2025)
Figure 103. North America Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production (K MT) Growth Rate (2020-2025)
Figure 106. China Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Share Forecast by Type (2026-2035)
